| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 678615 | 61154 | TRANKIMAZIN RETARD 3 mg COMPRIMIDOS | TRANKIMAZIN RETARD 3 mg COMPRIMIDOS, 30 comprimidos | 3 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61154/61154_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61154/61154_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1996-06-01 | 1 | 1 | 1 | 1996-06-01 | 1996-06-01 | 1 | 2011-02-11 | Lista IV | View Edit Delete | |||||||||||
| 678631 | 61153 | TRANKIMAZIN RETARD 2 mg COMPRIMIDOS | TRANKIMAZIN RETARD 2 mg COMPRIMIDOS, 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61153/61153_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61153/61153_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1996-06-01 | 1 | 1 | 1 | 1996-06-01 | 1996-06-01 | 1 | 2011-02-11 | Lista IV | View Edit Delete | |||||||||||
| 678656 | 61152 | TRANKIMAZIN RETARD 0,5 mg COMPRIMIDOS | TRANKIMAZIN RETARD 0,5 mg COMPRIMIDOS, 30 comprimidos | 0,5 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61152/61152_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61152/61152_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1996-06-01 | 1 | 1 | 1 | 1996-06-01 | 1996-06-01 | 1 | 2011-02-11 | Lista IV | View Edit Delete | |||||||||||
| 678672 | 61151 | TRANKIMAZIN RETARD 1 mg COMPRIMIDOS | TRANKIMAZIN RETARD 1 mg COMPRIMIDOS, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61151/61151_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61151/61151_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1996-06-01 | 1 | 1 | 1 | 1996-06-01 | 1996-06-01 | 1 | 2011-02-11 | Lista IV | View Edit Delete | |||||||||||
| 678932 | 73351 | MANIDIPINO VIATRIS 10 MG COMPRIMIDOS EFG | MANIDIPINO VIATRIS 10 MG COMPRIMIDOS EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73351/73351_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73351/73351_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2011-01-27 | 1 | 1 | 1 | 2011-01-27 | 2011-01-27 | 1 | 2011-07-11 | View Edit Delete | ||||||||||||
| 678941 | 73352 | MANIDIPINO VIATRIS 20 MG COMPRIMIDOS EFG | MANIDIPINO VIATRIS 20 MG COMPRIMIDOS EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73352/73352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73352/73352_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2011-01-27 | 1 | 1 | 1 | 2011-01-27 | 2011-01-27 | 1 | 2011-07-11 | View Edit Delete | ||||||||||||
| 679323 | 73819 | TAMSULOSINA VIATRIS PHARMACEUTICALS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | TAMSULOSINA VIATRIS PHARMACEUTICALS 0,4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 30 comprimidos | 0,4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73819/73819_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73819/73819_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2011-06-13 | 1 | 1 | 1 | 2013-05-12 | 2013-05-12 | 0 | 2018-11-09 | View Edit Delete | ||||||||||||
| 680715 | 74085 | MONTELUKAST VIATRIS 5 MG COMPRIMIDOS MASTICABLES EFG | MONTELUKAST VIATRIS 5 MG COMPRIMIDOS MASTICABLES EFG, 28 comprimidos (Al/Al) | 5 mg | 5 | 28 | 10 | 28 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74085/74085_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74085/74085_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2011-10-07 | 1 | 1 | 1 | 2012-12-18 | 2012-12-18 | 1 | 2013-02-26 | View Edit Delete | ||||||||||||
| 680734 | 74086 | MONTELUKAST VIATRIS 4 MG COMPRIMIDOS MASTICABLES EFG | MONTELUKAST VIATRIS 4 MG COMPRIMIDOS MASTICABLES EFG, 28 comprimidos (Al/Al) | 4 mg | 5 | 28 | 10 | 28 comprimidos (Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74086/74086_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74086/74086_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2011-10-07 | 1 | 1 | 1 | 2012-12-18 | 2012-12-18 | 1 | 2013-02-26 | View Edit Delete | ||||||||||||
| 679977 | 61049 | DEZACOR 22,75 mg/ml GOTAS ORALES EN SUSPENSION | DEZACOR 22,75 mg/ml GOTAS ORALES EN SUSPENSION, 1 frasco de 13 ml | 22,75 mg/ml | 6 | 13 | 26 | 1 frasco de 13 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61049/61049_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61049/61049_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 41329 | FAES FARMA S.A. | 1996-11-01 | 1 | 1 | 1 | 1996-11-01 | 1996-11-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 679969 | 61050 | ZAMENE 22,75 mg/ml GOTAS ORALES EN SUSPENSION | ZAMENE 22,75 mg/ml GOTAS ORALES EN SUSPENSION , 1 frasco de 13 ml | 22,75 mg/ml | 6 | 13 | 26 | 1 frasco de 13 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61050/61050_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61050/61050_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1803 | LABORATORIOS MENARINI S.A. | 1996-11-01 | 1 | 1 | 1 | 1996-11-01 | 1996-11-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 677469 | 61846 | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CLORXIL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 250 ml | 10 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61846/61846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61846/61846_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | LABORATORIOS HARTMANN S.A. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 2011-01-31 | 0 | 2012-11-12 | View Edit Delete | ||||||||||||
| 678649 | 63626 | AMBROXOL CINFA 3 MG/ML JARABE EFG | AMBROXOL CINFA 3 MG/ML JARABE EFG, 1 frasco de 200 ml | 3 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63626/63626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63626/63626_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2001-01-26 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 679688 | 61068 | PHARMAGRIP TOS Y CONGESTION SUSPENSION ORAL | PHARMAGRIP TOS Y CONGESTION SUSPENSION ORAL, 1 frasco de 125 ml | 250 mg/5 ml + 10 mg/5 ml + 30 mg/5 ml | 6 | 125 | 26 | 1 frasco de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61068/61068_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61068/61068_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 1996-03-01 | 1 | 1 | 1 | 2019-08-01 | 2019-08-01 | 1 | 2019-08-20 | View Edit Delete | ||||||||||||
| 676925 | 73232 | SOLUDRONATE SEMANAL 70 MG SOLUCION ORAL | SOLUDRONATE SEMANAL 70 MG SOLUCION ORAL 4 frascos unidosis de 100 ml | 70 mg | 6 | 4 | 17 | 4 frascos unidosis de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73232/73232_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73232/73232_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2495 | LABORATORIOS RUBIO S.A. | 2012-08-27 | 1 | 1 | 1 | 2012-08-27 | 2012-08-27 | 1 | 2014-04-12 | View Edit Delete | ||||||||||||
| 676735 | 73182 | VIMOVO 500 mg/20 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VIMOVO 500 mg/20 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 60 comprimidos | 500 mg/20 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73182/73182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73182/73182_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 2011-03-21 | 1 | 1 | 1 | 2011-03-21 | 2011-03-21 | 1 | 2011-07-15 | View Edit Delete | ||||||||||||
| 680762 | 74097 | CÁSCARA SAGRADA ARKOPHARMA CÁPSULAS DURAS | CÁSCARA SAGRADA ARKOPHARMA CÁPSULAS DURAS , 50 cápsulas | 250 mg | 6 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74097/74097_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74097/74097_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2011-05-23 | 1 | 1 | 1 | 2011-05-23 | 2011-05-23 | 0 | 2012-01-12 | View Edit Delete | ||||||||||||
| 677289 | 23661 | LARGACTIL 40mg/ml GOTAS ORALES EN SOLUCION | LARGACTIL 40mg/ml GOTAS ORALES EN SOLUCION , 1 frasco de 30 ml | 40 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/23661/23661_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/23661/23661_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 1955-06-01 | 1 | 1 | 1 | 1955-06-01 | 2010-12-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 680828 | 41573 | NEMACTIL 40mg/ml GOTAS ORALES EN SOLUCION | NEMACTIL 40mg/ml GOTAS ORALES EN SOLUCION, 1 frasco de 30 ml | 40 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41573/41573_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41573/41573_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 1965-10-01 | 1 | 4 | 4 | 2015-09-17 | 2015-09-17 | 1 | 2012-06-01 | View Edit Delete | ||||||||||||
| 677471 | 70121 | AMOXICILINA/ACIDO CLAVULANICO ARDINECLAV 100/12,5 mg/ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA/ACIDO CLAVULANICO ARDINECLAV 100/12,5 mg/ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml | 100 mg/ml + 12,5 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70121/70121_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70121/70121_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2008-10-02 | 1 | 1 | 1 | 2008-10-02 | 2011-02-10 | 1 | 2012-02-01 | View Edit Delete |
Page 250 of 1036, showing 20 records out of 20702 total, starting on record 4981, ending on 5000